118 related articles for article (PubMed ID: 1615925)
21. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement.
Tsukamoto N; Morita K; Maehara T; Okamoto K; Sakai H; Karasawa M; Naruse T; Omine M
Br J Haematol; 1994 Feb; 86(2):253-8. PubMed ID: 7911034
[TBL] [Abstract][Full Text] [Related]
22. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
Hyun BH; Gulati GL; Ashton JK
Clin Lab Med; 1990 Dec; 10(4):825-38. PubMed ID: 2272176
[TBL] [Abstract][Full Text] [Related]
23. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos.
Tefferi A; Thiele J; Vardiman JW
Cancer; 2009 Sep; 115(17):3842-7. PubMed ID: 19472396
[TBL] [Abstract][Full Text] [Related]
24. Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature.
Mertens F; Johansson B; Heim S; Kristoffersson U; Mitelman F
Leukemia; 1991 Mar; 5(3):214-20. PubMed ID: 2013980
[TBL] [Abstract][Full Text] [Related]
25. Detection of the activating JAK2 V617F mutation in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative diseases.
Horn T; Kremer M; Dechow T; Pfeifer WM; Geist B; Perker M; Duyster J; Quintanilla-Martinez L; Fend F
J Mol Diagn; 2006 Jul; 8(3):299-304. PubMed ID: 16825501
[TBL] [Abstract][Full Text] [Related]
26. Hematopathologic findings in the myeloproliferative disorders.
Dickstein JI; Vardiman JW
Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
[TBL] [Abstract][Full Text] [Related]
27. The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview.
Tefferi A
Mayo Clin Proc; 1998 Dec; 73(12):1177-84. PubMed ID: 9868417
[TBL] [Abstract][Full Text] [Related]
28. A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemia.
Bacher U; Haferlach T; Kern W; Harich HD; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2007 May; 175(1):52-6. PubMed ID: 17498558
[TBL] [Abstract][Full Text] [Related]
29. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
Haferlach T; Kern W; Schnittger S; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S59-61. PubMed ID: 15124674
[TBL] [Abstract][Full Text] [Related]
30. [Clinical application of BCR/ABL probes in myeloproliferative disorders].
Ma JL; Chen BA; Tang M; He YJ; Ding JH; Gao C; Wang J; Cheng J; Zhao G; Li Z; Shen L; DU HZ; Wu F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):958-62. PubMed ID: 23998593
[TBL] [Abstract][Full Text] [Related]
31. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population.
Rudzki Z; Papla B; Stachura J
Pol J Pathol; 2004; 55(1):13-23. PubMed ID: 15195702
[TBL] [Abstract][Full Text] [Related]
32. High reliability and sensitivity of the BCR/ABL1 D-FISH test for the detection of BCR/ABL rearrangements.
Pelz AF; Kröning H; Franke A; Wieacker P; Stumm M
Ann Hematol; 2002 Mar; 81(3):147-53. PubMed ID: 11904740
[TBL] [Abstract][Full Text] [Related]
33. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
Nakata Y
Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
[TBL] [Abstract][Full Text] [Related]
34. Abnormal chromatin clumping in granulocytes in a case of Ph1-negative, BCR-ABL rearrangement positive, haematologically atypical chronic myeloid leukaemia (CML).
Tertian G; Misrahi M; Diallo D; Mielot F; Leonard C; Salmeron S; Tchernia G
Nouv Rev Fr Hematol (1978); 1995; 37(4):245-7. PubMed ID: 8904205
[TBL] [Abstract][Full Text] [Related]
35. Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates.
Yoon SY; Li CY; Tefferi A
Eur J Haematol; 2000 Sep; 65(3):170-4. PubMed ID: 11007052
[TBL] [Abstract][Full Text] [Related]
36. Essential differences in clinical and bone marrow features in BCR/ABL-positive thrombocythemia compared to thrombocythemia in the BCR/ABL-negative myeloproliferative neoplasms essential thrombocythemia and polycythemia vera.
Michiels JJ; Pich A; De Raeve H; Gadisseur A
Acta Haematol; 2015; 133(1):52-5. PubMed ID: 25116159
[No Abstract] [Full Text] [Related]
37. Lineage-specific clonality analysis of chronic myeloproliferative disorders and myelodysplastic syndrome by human androgen receptor assay.
Jáksó P; Kereskai L; Molnár L; Pajor L
Pathol Oncol Res; 2007; 13(2):114-22. PubMed ID: 17607372
[TBL] [Abstract][Full Text] [Related]
38. Pathology of the myeloproliferative diseases.
George TI; Arber DA
Hematol Oncol Clin North Am; 2003 Oct; 17(5):1101-27. PubMed ID: 14560777
[TBL] [Abstract][Full Text] [Related]
39. Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia.
Kreipe H; Jaquet K; Felgner J; Radzun HJ; Parwaresch MR
Blood; 1991 Oct; 78(7):1814-7. PubMed ID: 1680495
[TBL] [Abstract][Full Text] [Related]
40. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
